Cargando…
CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression
Our previous study shows that cellular retinoic acid binding protein II (CRABP-II) is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and pre-cancerous lesions, but not detected in normal pancreatic tissues. In this study, we show that deletion of CRABP-II in PDAC cells by CRISPR/Cas9 does...
Autores principales: | Yu, Shuiliang, Parameswaran, Neetha, Li, Ming, Wang, Yiwei, Jackson, Mark W., Liu, Huiping, Xin, Wei, Zhou, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581040/ https://www.ncbi.nlm.nih.gov/pubmed/28881741 http://dx.doi.org/10.18632/oncotarget.14194 |
Ejemplares similares
-
Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling
por: Yu, Shuiliang, et al.
Publicado: (2022) -
Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer
por: Zhang, Chuanfeng, et al.
Publicado: (2022) -
Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity
por: Zhang, Song, et al.
Publicado: (2018) -
Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
por: Smigiel, Jacob M., et al.
Publicado: (2018) -
4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5
por: Ju, Jing, et al.
Publicado: (2018)